![]() |
|
Antigen | HYAL1 antibody - N-terminal region |
Lot Number | QC23783 |
Method validated | Immunohistochemistry |
Positive Control | Testes of Hyal1 +/+ mouse |
Negative Control | Testes of Hyal1 -/- mouse |
Notes | ABIN2784343 does detect mouse HYAL1 by immunohistochemistry in paraffin sections. The immunohistochemistry is based on increased signal in wild type mouse testes compared to Hyal1-/- mouse testes. |
Primary Antibody | ABIN2784343 |
Secondary Antibody | Goat-anti-rabbit AF568 |
Protocol |
|
Application Notes | Optimal working dilutions should be determined experimentally by the investigator. |
Comment |
Antigen size: 435 AA |
Restrictions | For Research Use only |
Format | Liquid |
Concentration | Lot specific |
Buffer | Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose. |
Preservative | Sodium azide |
Precaution of Use | This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only. |
Handling Advice | Avoid repeated freeze-thaw cycles. |
Storage | -20 °C |
Storage Comment | For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles. |
Supplier Images |
Background publications |
Poola, Abraham, Marshalleck, Yue, Lokeshwar, Bonney, Dewitty: "Molecular risk assessment for breast cancer development in patients with ductal hyperplasias." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 14, Issue 4, pp. 1274-80, 2008 (PubMed).
|